Amplification of MDM2 inhibits MyoD-mediated myogenesis

Molecular and Cellular Biology

Volumn 16, Issue 9, 1996, Pages 5048-5057

  Fiddler, Troy A ^a   Smith, Leslie ^a   Tapscott, Stephen J ^b   Thayer, Mathew J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLE PROTEIN;

ANIMAL CELL; ARTICLE; CHROMOSOME 14; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION;

ANIMALIA;

EID: 0029743891     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.9.5048     Document Type: Article

References (59)

1. Barr, F. G., N. Galili, J. Holick, J. A. Biegel, G. Rovera, and B. S. Emanuel. 1993. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3:113-117.
2. Budowle, B., and F. S. Baechtel. 1990. Modifications to improve the effectiveness of restriction fragment length polymorphism typing. Appl. Theor. Electrophor. 1:181-187.
3. Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
4. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
5. Dias, P., D. M. Parham, D. N. Shapiro, B. L. Webber, and P. J. Houghton. 1990. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am. J. Pathol. 137:1283-1291.
6. Falcone, G., F. Tato, and S. Alema. 1985. Distinctive effects of the viral oncogenes myc, erb, fps, and src on the differentiation program of quail myogenic cells. Proc. Natl. Acad. Sci. USA 82:426-430.
7. Favaloro, J., R. Freisman, and R. Kamen. 1980. Transcription maps of polyoma virus-specific RNA: analysis by two dimensional nuclease S1 gel mapping. Methods Enzymol. 65:718-749.
8. Fiddler, T., and M. Thayer. Unpublished observations.
9. Fiszman, M. Y., and P. Fuchs. 1975. Temperature-sensitive expression of differentiation in transformed myoblasts. Nature (London) 254:429-431.
10. Fournier, R. E. K. 1981. A general high-efficiency procedure for production of microcell hybrids. Proc. Natl. Acad. Sci. USA 78:6349-6353.
11. Garson, J. A., J. Clayton, P. McIntyre, and J. T. Kemshead. 1986. N-myc oncogene amplification in rhabdomyosarcoma at release. Lancet i:1496. (Letter.)
12. Garvin, A. J., W. S. Stanley, D. D. Bennett, J. L. Sullivan, and D. A. Sens. 1986. The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am. J. Pathol. 125:208-217.
13. Gossett, L. A., W. Zhang, and E. N. Olson. 1988. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes. J. Cell Biol. 106:2127-2137.
14. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdari, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
15. Haines, D. S., J. E. Landers, L. J. Engle, and D. L. George. 1994. Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14:1171-1178.
16. Hazelton, B. J., J. A. Houghton, D. M. Parham, E. C. Douglass, P. M. Torrance, H. Holt, and P. J. Houghton. 1987. Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res. 47: 4501-4507.
17. Holtzer, H., J. Biehl, G. Yeoh, R. Meganathan, and A. Kaji. 1975. Effect of oncogenic virus on muscle differentiation. Proc. Natl. Acad. Sci. USA 72: 4051-4055.
18. Houghton, P. Personal communication.
19. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dcpendent kinase CDK4. Genes Dev. 7:331-342.
20. Khatib, Z. A., H. Malsushime, M. Valentine, D. N. Shapiro, C. J. Sherr, and A. T. Look. 1993. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53:5535-5541.
21. Kinzler, K. W., S. H. Bigner, D. D. Bigner, J. M. Trent, M. L. Law, S. J. O'Brien, A. J. Wong, and B. Vogelstein. 1987. Identification of an amplified, highly expressed gene in a human glioma. Science 236:70-73.
22. Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
23. Lassar, A. B., M. J. Thayer, R. W. Overall, and H. Weintraub. 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58:659-667.
24. Ludecke, H.-J., G. Senger, U. Claussen, and B. Horsthemke. 1989. Cloning defined regions of the human genome by microdissection of banded chromosomes and enzymatic amplification. Nature (London) 338:348-350.
25. Lugor, T. C., B. Handelin, A. M. Killary, D. E. Housman, and R. E. Fournier. 1987. Isolation of microcell hybrid clones containing retroviral insertions into specific human chromosomes. Mol. Cell. Biol. 7:2814-2820.
26. Martin, K., D. Trouche, C. Hagemeier, T. S. Sorensen, N. B. La-Thangue, and T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (London) 375:691-694.
27. Mitani, K., H. Kurosawa, A. Suzuki, Y. Hayashi, R. Hanada, K. Yamamoto, A. Komatsu, N. Kobayashi, Y. Nakagome, and M. Yamada. 1986. Amplification of N-myc in a rhabdomyosarcoma. Jpn. J. Cancer Res. 77:1062-1065.
28. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
29. Nelson, D. L., A. Ballabio, M. F. Victoria, M. Pieretti, R. D. Bies, R. A. Gibbs, J. A. Maley, A. C. Chinault, T. D. Webster, and C. T. Caskey. 1991. Alu-primed polymerase chain reaction for regional assignment of 110 yeast artificial chromosome clones from the human X chromosome: identification of clones associated with a disease locus. Proc. Natl. Acad. Sci. USA 88: 6157-6161.
30. Nelson, D. L., S. A. Ledbetter, L. Corbo, M. F. Victoria, S. R. Ramirez, T. D. Webster, D. H. Ledbetter, and C. T. Caskey. 1989. Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc. Natl. Acad. Sci. USA 86:6686-6690.
31. Newsham, I., U. Claussen, H. J. Ludecke, M. Mason, G. Senger, B. Horsthemke, and W. Cavenee. 1991. Microdissection of chromosome band 11p15.5: characterization of probes mapping distal to the HBBC locus. Genes Chromosome Cancer. 3:108-116.
32. Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (London) 358:80-83.
33. Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (London) 362:857-860.
34. Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol. 154:261-272.
35. Olson, E. N., G. Spizz, and M. A. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104-2111.
36. Payne, P. A., E. N. Olson, P. Hsiau, R. Roberts, M. B. Perryman, and M. D. Schneider. 1987. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc. Natl. Acad. Sci. USA 84:8956-8960.
37. Peterson, C. A., H. Gordon, Z. W. Hall, B. M. Paterson, and H. M. Blau. 1990. Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell 62:493-502.
38. Rao, S. S., C. Chu, and S. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
39. Reifenberger, G., J. Reifenberger, K. Ichimura, P. S. Meltzer, and V. P. Collins. 1994. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res. 54:4299-4303.
40. Roberts, W. M., E. C. Douglass, S. C. Peiper, P. J. Houghton, and A. T. Look. 1989. Amplification of the gli gene in childhood sarcomas. Cancer Res. 49:5407-5413.
41. Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 264:1467-1471.
42. Schneider, M. D., M. B. Perryman, P. A. Payne, G. Spizz, R. Roberts, and E. N. Olson. 1987. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation. Mol. Cell. Biol. 7:1973-1977.
43. Semble, H. J., D. K. Johnson, E. M. Rinchik, and W. K. Cavenee. 1990. Rhabdomyosarcoma-associated locus and MYOD1 are syntenic but separate loci on the short arm of human chromosome 11. Proc. Natl. Acad. Sci. USA 87:2182-2186.
44. Seed, B., and J.-Y. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acetyltransferase activity. Gene 67:271-277.
45. Shapiro, D. N., J. E. Sublett, B. Li, J. R. Downing, and C. W. Naeve. 1993. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer. Res. 53:5108-5112.
46. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
47. Smith, L., and M. Thayer. Unpublished observations.
48. Stark, G. R., M. Debatisse, E. Giulotto, and G. M. Wahl. 1989. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57:901-908.
49. Tapscott, S., and M. Thayer. Unpublished observations.
50. Tapscott, S. J., M. J. Thayer, and H. Weintraub. 1993. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259:1450-1453.
51. Thayer, M. Unpublished observations.
52. Thulin, J., and M. Thayer. Unpublished observations.
53. Tlsty, T. D. 1990. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. USA 87:3132-3136.
54. Trask, B., and D. Pinkel. 1990. Flow cytometry. Academic Press, New York.
55. Webster, K. A., G. E. Muscat, and L. Kedes. 1988. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (London) 332:553-557.
56. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
57. Xiao, Z. X., J. Chen, A. J. Levine, N. Modjtahedi, J. Xing, W. R. Sellers, and D. M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (London) 375:694-698.
58. Yunis, J. J., and M. E. Chandler. 1978. High-resolution chromosome analysis in clinical medicine. Prog. Clin. Pathol. 7:267-288.
59. Zauberman, A., Y. Barak, N. Ragimov, N. Levy, and M. Oren. 1993. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J. 12:2799-2808.